[HTML][HTML] Oral administration of PET tracers: Current status

GS de Souza, DBA Mantovani, P Mossel… - Journal of Controlled …, 2023 - Elsevier
The oral route is the most widely used and preferable way of drug administration. Several
pharmacokinetic processes play a role in the distribution of administered drugs. Therefore …

Nuclear imaging in pediatric cardiology: principles and applications

M Venet, MK Friedberg, L Mertens, J Baranger… - Frontiers in …, 2022 - frontiersin.org
Nuclear imaging plays a unique role within diagnostic imaging since it focuses on cellular
and molecular processes. Using different radiotracers and detection techniques such as the …

A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti–PD-L1 mAb Combination to Enhance the Antitumor Effect

X Wen, C Shi, X Zeng, L Zhao, L Yao, Z Liu, L Feng… - Clinical Cancer …, 2022 - AACR
Purpose: Efforts have been devoted to select eligible candidates for PD-1/PD-L1 immune
checkpoint blocker (ICB) immunotherapy. Here, we have a serendipitous finding of positron …

First-in-humans PET imaging of KRASG12C mutation status in non–small cell lung and colorectal cancer patients using [18F] PFPMD

X Li, J Ye, J Wang, Z Quan, G Li, W Ma… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Kirsten rat sarcoma (KRAS) mutations are an important marker for tumor-targeted therapy. In
this study, we sought to develop a KRASG12C oncoprotein–targeted PET tracer and to …

68Ga-MY6349 PET/CT imaging to assess Trop2 expression in multiple types of cancer

H Chen, L Zhao, Y Pang, J Shi, H Gao, Y Sun… - The Journal of Clinical …, 2024 - jci.org
BACKGROUND Considering that trophoblast cell-surface antigen 2 (Trop2) is
overexpressed in a wide range of human epithelial cancers, it presents an attractive target …

Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC)

IM Jackson, SJ Lee, AR Sowa, ME Rodnick… - EJNMMI …, 2020 - Springer
Abstract Background In the US, EU and elsewhere, basic clinical research studies with
positron emission tomography (PET) radiotracers that are generally recognized as safe and …

MIRD Pamphlet No. 30: MIRDfit—A Tool for Fitting of Biodistribution Time–Activity Data for Internal Dosimetry

LM Carter, JCO Ramos, SB Schuerrle… - Journal of Nuclear …, 2024 - jnm.snmjournals.org
In nuclear medicine, estimating the number of radioactive decays that occur in a source
organ per unit administered activity of a radiopharmaceutical (ie, the time-integrated activity …

[HTML][HTML] Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography

L Li, L Wan, H Zhao, C Wang, W Wei… - Quantitative Imaging in …, 2023 - ncbi.nlm.nih.gov
Background [18 F] F-FDG,[68 Ga] Ga-PSMA-11, and [68 Ga] Ga-FAPI-04 have achieved
good results in multiple clinical trials and clinical practice, but the imaging of these tracers is …

First-in-human healthy volunteer dosimetry studies of the excitatory amino acid transporter 2 (EAAT2) PET imaging tracer methyl N4-(7-[18F] fluoro-9H-fluoren-2-yl) …

CK Chao, J Blecha, I Polvoy, RM Nillo, Y Seo… - Nuclear Medicine and …, 2025 - Elsevier
Objective and background The objective of this first-in-human study was to investigate the
radiosynthesis, and the preliminary safety, biodistribution, and organ radiation dosimetry of …

2-[18F]Fluoropropionic Acid PET Imaging of Doxorubicin-Induced Cardiotoxicity

JA Azcona, AS Wacker, CH Lee, EK Fung… - Molecular Imaging and …, 2025 - Springer
Purpose Treatment of pediatric cancers with doxorubicin is a common and predictable
cause of cardiomyopathy. Early diagnosis of treatment-induced cardiotoxicity and …